Ergomed (ERGO)

 

ERGO Share PerformanceMore

52 week high216.90 28/02/17
52 week low117.00 16/09/16
52 week change 64.00 (47.94%)
4 week volume723,629 29/05/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

PeproStat study passes recruitment mid-point

RNS Number: 6561I Ergomed plc 21 June 2017 PRESS RELEASE FOR IMMEDIATE RELEASE PeproStat Phase IIb study passes recruitment mid-point ahead of schedule - Top line results brought forward to Q4 2017 London, UK - 21 June 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company dedicated to the provision of specialised services to the...

Ergomed resolutions passed at AGM

Ergomed has confirmed that all resolutions proposed at its annual general meeting on Friday were passed. At 8:34am: (LON...

Result of AGM

RNS Number: 3958I Ergomed plc 16 June 2017 PRESS RELEASE FOR IMMEDIATE RELEASE Results of 2017 Annual General Meeting London, UK -16 June 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today announces ...

Ergomed appoints CEO

Ergomed has appointed Dr Dan Weng as its new chief executive and a board director from 1 July. He will takeover the rol...

Appointment of CEO

Notification of any change to a company’s board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director

Ergomed to present at the Shares Spotlight Evening in Manchester on 29 June 2017

Shares and AJ Bell Media are pleased to present eg Solutions, Ergomed, PrimaryBid and Solo Oil at their Manchester eveni...

Appointment of N+1 Singer as joint broker

RNS Number: 7234F Ergomed plc 22 May 2017 PRESS RELEASE FOR IMMEDIATE RELEASE Appointment of N+1 Singer as joint broker London, UK - 22 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today annou...

Annual Report and Notice of AGM

RNS Number: 0569F Ergomed plc 12 May 2017 Annual Report and Notice of AGM London, UK - 12 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today announces that it will hold its Annual General Meeting at the off...

Fundamental DataMore

P/E ratio151.923
EPS1.3
Dividend yield0 %

Equity Research (ERGO)

equity development
Ergomed Plc
08/05/2017
Ergomed offers clinical trial and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies. Aeterna Zentaris, a co-development partner of...
equity development
Ergomed Plc
12/04/2017
Ergomed offers clinical trial and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies. 2016 perfectly highlighted the strengths of the...
equity development
Ergomed Plc
25/01/2017
Ergomed offers clinical trial and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies. The recent period end update for Ergomed confirmed...

Latest discussion posts More

  • Results webinar

    If you would like to hear management present the preliminary results for the year ended 31 December 2016 for Ergomed we will be hosting a webinar on Wednesday 29th March at ...
    22-Mar-2017
    equity_dev
  • See management present

    If you would like to hear Stephen Stamp, Chief Finance Officer, present on behalf of Ergomed he will be appearing at our next investor forum on the evening of Wednesday 25th of ...
    17-Jan-2017
    equity_dev
  • Webinar with management

    We will be hosting a webinar with the management of Ergomed tomorrow (Tuesday 27th September) at 11.15. There will be a presentation of the interim results lasting around ...
    26-Sep-2016
    equity_dev

Users' HoldingsMore

Users who hold Ergomed also hold..
TREATT36%
ID:ISIN:VGG9828A119427%
INSPIRED ENERGY27%
CENTRAL ASIA27%
FEVERTREE DRK27%

Codes & Symbols

ISINGB00BN7ZCY67
SymbolsERGO, LSE:ERGO, ERGO.L, ERGO:LN, LON:ERGO, XLON:ERGO